Accentis nv

Accentis nv

0.03
EUR
+0.00
(-1.92%)
32.83MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
0.01
0.01
- -
0.01
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
Book Value per Share
0.03
0.03
0.04
0.04
0.04
0.05
0.05
0.06
0.07
0.03
0.03
0.03
0.03
0.03
Tangible Book Value per Share
0.03
0.03
0.04
0.04
0.04
0.05
0.05
0.06
0.07
0.03
0.03
0.03
0.03
0.03
Basic Weighted Avg Shares
1,268
1,268
1,268
1,268
1,268
1,268
1,268
1,268
1,263
1,263
1,263
1,263
1,263
1,263
Sales/Revenue/Turnover
20
19
20
20
19
20
20
20
21
8
7
6
6
- -
Operating Margin (%)
59.78
60.12
54.81
53.25
52.19
50.33
45.54
51.99
39.75
47.34
58.32
62.67
59.17
- -
Depreciation Expense
-1
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
- -
3
4
5
7
8
6
17
- -
3
1
1
- -
Effective Tax Rate (%)
- -
22.25
36.4
32.25
11.07
- -
22.96
19.46
1.14
73.39
21.67
35.03
20.88
- -
Profit Margin (%)
-3.56
1.99
14.51
18.32
23.43
36.3
39.96
29.1
81.44
4.48
37.41
12.24
21.48
- -
Working Capital
-4
-2
-3
-3
-1
-1
-2
-3
65
13
16
16
20
20
LT Debt
77
66
53
65
57
47
47
42
15
14
12
10
8
7
Total Equity
42
43
45
49
54
61
69
75
91
36
38
39
40
42
Return on Invested Capital (%)
- -
3.42
5.79
5.16
5.91
- -
8.07
5.97
15.84
0.83
5.97
1.93
2.96
- -
Return on Capital (%)
- -
3.43
5.06
5.17
5.92
- -
8.1
5.98
16.04
0.83
6.48
2.56
3.55
- -
Return on Common Equity (%)
-1.7
0.88
6.52
7.8
8.89
12.69
12.17
8.12
20.56
0.53
7.03
2.01
3.12
- -

Capital Structure

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
8
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,263
1,263
1,263
Market Capitalization
37
33
33

Working Capital

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
23
23
23
Cash, Cash Equivalents & STI
22
22
11
Accounts Receivable, Net
1
- -
1
Inventories
- -
- -
- -
Total Current Liabilities
3
3
3
Payables & Accruals
- -
- -
- -
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.64%
-5.18%
3.17%
Free Cash Flow
0.41%
-15.89%
-23.81%
Net Income, GAAP
84.57%
150.36%
59.05%
Sales/Revenue/Turnover
-8.38%
-17.02%
-9.35%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
6
2025
- -
- -
6
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Cornelia Cok
Full Time Employees
5
Sector
Finance
Industry
Real estate development
Address
Noorderlaan 139/3V Antwerp VL Belgium 2030
IPO Date
May 26, 1997
Business
Accentis N.V. (ACCB.BR) specializes in owning and managing industrial and semi-industrial real estate properties, primarily in Belgium and Germany, with additional operations in France, Slovakia, and the Netherlands. Founded in 1994 and headquartered in Antwerp, Belgium, the company pursues a long-term strategy to maximize portfolio value through optimized rental income and active asset management; its properties include multifunctional complexes with manufacturing spaces, logistics facilities, storage units, offices, showrooms, and parking, such as Accentis Business Center in Lier featuring recent expansions of approximately 2,000 square meters of new warehouses. The portfolio serves tenants across sectors including engineering, technology, pharmaceuticals, medical distribution, geographic data services, dermatology, and social secretariats, with key properties in locations like Brugge, Dinant, Evergem, Ieper, Overpelt, and Sint-Truiden. Recent developments include the successful delivery and occupancy of two new warehouses at Accentis Business Center Lier by tenants 1STDvision and Strans in January 2025, alongside lease renewals with long-term occupant Descartes for three additional years and LeoPharma; in April 2025, the company welcomed new tenant Delta-EM into a 170-square-meter office unit and expanded space for Revvity by 100 square meters of logistics area, while implementing a waterless urinal pilot project to enhance sustainability. In November 2024, Avineon relocated to a 300-square-meter unit at the same site, and SD Worx expanded its consulting rooms; on August 19, 2025, Accentis appointed a new CEO as part of ongoing leadership enhancements. These initiatives reflect active portfolio optimization, tenant diversification, and operational improvements amid half-year results released on August 25, 2025.